4.3 Limitations
There were a few limitations to the conclusions that could be made from
this study. Because subjects were healthy, the pharmacokinetic data
collected represented the best case and did not include variability due
to patient covariates. As the study was performed in a small number of
subjects, conclusions related to safety can only be made for common
adverse events, but not rare adverse events.